205 related articles for article (PubMed ID: 29121273)
1. Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999-2014).
Jorge AM; Lu N; Zhang Y; Rai SK; Choi HK
Rheumatology (Oxford); 2018 Feb; 57(2):337-344. PubMed ID: 29121273
[TBL] [Abstract][Full Text] [Related]
2. The unclosing premature mortality gap in gout: a general population-based study.
Fisher MC; Rai SK; Lu N; Zhang Y; Choi HK
Ann Rheum Dis; 2017 Jul; 76(7):1289-1294. PubMed ID: 28122760
[TBL] [Abstract][Full Text] [Related]
3. Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study.
D'Silva KM; Li L; Lu N; Ogdie A; Avina-Zubieta JA; Choi HK
Rheumatology (Oxford); 2021 Jun; 60(6):2653-2660. PubMed ID: 33175975
[TBL] [Abstract][Full Text] [Related]
4. Improved survival in rheumatoid arthritis: a general population-based cohort study.
Zhang Y; Lu N; Peloquin C; Dubreuil M; Neogi T; Aviña-Zubieta JA; Rai SK; Choi HK
Ann Rheum Dis; 2017 Feb; 76(2):408-413. PubMed ID: 27338777
[TBL] [Abstract][Full Text] [Related]
5. Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
Lorenzo-Vizcaya A; Isenberg D
Lupus; 2021 Apr; 30(5):702-706. PubMed ID: 33472522
[TBL] [Abstract][Full Text] [Related]
6. All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study.
Moghaddam B; Marozoff S; Li L; Sayre EC; Zubieta JAA
Rheumatology (Oxford); 2021 Dec; 61(1):367-376. PubMed ID: 33871600
[TBL] [Abstract][Full Text] [Related]
7. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.
Lacaille D; Avina-Zubieta JA; Sayre EC; Abrahamowicz M
Ann Rheum Dis; 2017 Jun; 76(6):1057-1063. PubMed ID: 28031164
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study.
Lai CH; Lai WW; Chiou MJ; Lin WC; Yang YJ; Li CY; Tsai LM
Ann Rheum Dis; 2016 Jul; 75(7):1350-6. PubMed ID: 26286017
[TBL] [Abstract][Full Text] [Related]
9. Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality.
Icen M; Nicola PJ; Maradit-Kremers H; Crowson CS; Therneau TM; Matteson EL; Gabriel SE
J Rheumatol; 2009 Jan; 36(1):50-7. PubMed ID: 19004043
[TBL] [Abstract][Full Text] [Related]
10. Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012.
Rees F; Doherty M; Grainge MJ; Lanyon P; Davenport G; Zhang W
Rheumatology (Oxford); 2016 May; 55(5):854-60. PubMed ID: 26748350
[TBL] [Abstract][Full Text] [Related]
11. Temporal relationships between systemic lupus erythematosus and comorbidities.
Kuo CF; Chou IJ; Rees F; Grainge MJ; Lanyon P; Davenport G; Mallen CD; Chung TT; Chen JS; Zhang W; Doherty M
Rheumatology (Oxford); 2019 May; 58(5):840-848. PubMed ID: 30590795
[TBL] [Abstract][Full Text] [Related]
12. Onset age affects mortality and renal outcome of female systemic lupus erythematosus patients: a nationwide population-based study in Taiwan.
Chen YM; Lin CH; Chen HH; Chang SN; Hsieh TY; Hung WT; Hsieh CW; Lai KL; Lan JL; Chen DY; Lan TH
Rheumatology (Oxford); 2014 Jan; 53(1):180-5. PubMed ID: 24136069
[TBL] [Abstract][Full Text] [Related]
13. Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort.
Reppe Moe SE; Molberg Ø; Strøm EH; Lerang K
Lupus; 2019 Jun; 28(7):818-825. PubMed ID: 31072277
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study.
Lai CH; Hsieh CY; Barnado A; Huang LC; Chen SC; Tsai LM; Shyr Y; Li CY
Rheumatology (Oxford); 2020 Jun; 59(6):1355-1363. PubMed ID: 31600392
[TBL] [Abstract][Full Text] [Related]
15. Association of systemic lupus erythematosus and sleep disorders: a nationwide population-based cohort study.
Chung WS; Lin CL; Kao CH
Lupus; 2016 Apr; 25(4):382-8. PubMed ID: 26585071
[TBL] [Abstract][Full Text] [Related]
16. Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.
Bultink IEM; de Vries F; van Vollenhoven RF; Lalmohamed A
Rheumatology (Oxford); 2021 Jan; 60(1):207-216. PubMed ID: 32653901
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors of osteomyelitis in adult and pediatric systemic lupus erythematosus: a nationwide, population-based cohort study.
Huang YF; Chang YS; Chen WS; Tsao YP; Wang WH; Liao HT; Tsai CY; Lai CC
Lupus; 2019 Jan; 28(1):19-26. PubMed ID: 30458691
[TBL] [Abstract][Full Text] [Related]
18. Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013.
Falasinnu T; Rossides M; Chaichian Y; Simard JF
Public Health Rep; 2018; 133(4):481-488. PubMed ID: 29928843
[TBL] [Abstract][Full Text] [Related]
19. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
[TBL] [Abstract][Full Text] [Related]
20. The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study.
Hermansen ML; Lindhardsen J; Torp-Pedersen C; Faurschou M; Jacobsen S
Rheumatology (Oxford); 2017 May; 56(5):709-715. PubMed ID: 28053276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
